CCR8 Molekülinformation
Molecule Name
C-C chemokine receptor type 8
Molekülalias
CC chemokine receptor 8,CDw198,ChemR1,CKRL1,CKR-L1,CKRL1,CY6,GPRCL1,GPRCY6,GPR-CY6,TER-1
Drug Development Progress
Anzahl der klinischen Arzneimittel21
Anzahl der inverkehr gebrachten Arzneimittel0
Höchste Forschungs- und EntwicklungsphasePhase 3 Clinical
Target-Alias
Chemokine (C-C) Receptor 8，CC Chemokine Receptor 8，CDw198 Antigen，C-C CKR-8，CC-CKR-8，CCR-8，CMKBRL2，C-C Motif Chemokine Receptor 8，CC chemokine receptor CHEMR1，C-C chemokine receptor type 8，Chemokine (C-C Motif) Receptor 8，C-C Chemokine Receptor Type 8，CC Chemokine Receptor CHEMR1，Chemokine Receptor-Like 1，Chemokine (C-C) Receptor-Like 2，CC-Chemokine Receptor Chemr1，CD_antigen=CDw198，Chemokine receptor-like 1，CKRL1，CKR-L1，CMKBR8，GPRCY6，GPR-CY6，TER1，CDw198，CY6
Molekülhintergrund
CCR8 is a G protein-coupled chemokine receptor expressed on regulatory T cells and in tumor microenvironments, mediating chemotaxis, immune regulation, and pathological processes like inflammation or cancer progression. The unconjugated anti-human CCR8 antibody enables specific detection of human CCR8.
CCR8 Produktliste
You Have Viewed 0 Of 0 Results
Antikörperprojekt-Handelsplattform
| Projektname | Projektphase | Molekültyp | Molekülquelle | Krankheitsgebiet | Indikationen |
|---|---|---|---|---|---|
| CCR8 mAb - 01 | PCC | Monoclonal | Humanized Mouse | Solid Tumor | Solid tumor |
| CCR8 mAb - 02 | Lead | Monoclonal | Humanized Mouse | Solid Tumor | Solid tumor |
| CCR8 mAb - 03 | PCC | Monoclonal | Humanized Mouse | Solid Tumor | Solid tumor |
- Projektname
- CCR8 mAb - 01
- Projektphase
- PCC
- Molekültyp
- Monoclonal
- Molekülquelle
- Humanized Mouse
- Krankheitsgebiet
- Solid Tumor
- Indikationen
- Solid tumor
- Projektname
- CCR8 mAb - 02
- Projektphase
- Lead
- Molekültyp
- Monoclonal
- Molekülquelle
- Humanized Mouse
- Krankheitsgebiet
- Solid Tumor
- Indikationen
- Solid tumor
- Projektname
- CCR8 mAb - 03
- Projektphase
- PCC
- Molekültyp
- Monoclonal
- Molekülquelle
- Humanized Mouse
- Krankheitsgebiet
- Solid Tumor
- Indikationen
- Solid tumor
Lizenzierungszusammenarbeit
| Projektname | Arzneimitteltyp | Therapiegebiet | Indikationen | Stufe | Rechtsgebiet |
|---|---|---|---|---|---|
| CCR8 Humanized Antibody | Bispecific antibody | Oncology/Cancer | Solid Tumor | Preclinical | Global |
- Projektname
- CCR8 Humanized Antibody
- Arzneimitteltyp
- Bispecific antibody
- Therapiegebiet
- Oncology/Cancer
- Indikationen
- Solid Tumor
- Stufe
- Preclinical
- Rechtsgebiet
- Global